Evaluation of a mouthrinse containing guava leaf extract as part of comprehensive oral care regimen- a randomized placebo-controlled clinical trial.


Journal

BMC complementary and alternative medicine
ISSN: 1472-6882
Titre abrégé: BMC Complement Altern Med
Pays: England
ID NLM: 101088661

Informations de publication

Date de publication:
21 Nov 2019
Historique:
received: 17 07 2019
accepted: 04 11 2019
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 16 1 2020
Statut: epublish

Résumé

The control of biofilm adherence on tooth surface has always been the keystone of periodontal therapeutic systems. However, prevalence of gingivitis suggest inadequacy of self-performed oral hygiene measures and need for adjunctive aid for mechanical plaque control. Oral rinses containing chlorhexidine, has been widely used however, with certain limitations. Herbal products have been used widely reflecting its action as alternative and complementary remedy. Hence, the purpose of the present study was to evaluate the antimicrobial and antioxidant efficacy of a Guava leaf extract based mouthrinse in patients with chronic generalized gingivitis as an adjunct to oral prophylaxis. Sixty subjects (n = 20) in compliance with the inclusion criteria were randomly assigned to one of the 3 study groups i.e. Group A- 0.15%Guava mouth rinse, Group B- 0.2% Chlorhexidine (CHX) mouth rinse, Group C- Distilled water (placebo). All the participants received professional oral prophylaxis and were dispensed with experimental mouth rinses and instructed to use for period of 30 days. Clinical parameters such as gingival index, plaque index along with microbial colony forming units using plaque samples and antioxidant levels in saliva were estimated at baseline, 30 and 90 days' time intervals. All 3 groups showed gradual reduction in GI, PI and microbial counts. Considering the mean scores of recorded parameters at the scheduled time intervals, notable changes were observed between chlorhexidine and guava mouth rinse compared to placebo group. Although there was improvement in the antioxidant status in all study participants, yet there was no statistically significant difference observed. Guava mouth rinse can be used as an empirical adjunct to professional oral prophylaxis owing to its multifactorial properties and favourable acceptance. However, long term studies need to be conducted to validate its use for an extended period of time. The clinical trial has been prospectively registered on 17th February 2017 by the Clinical Trials Registry-India (CTRI/2017/02/007898).

Sections du résumé

BACKGROUND BACKGROUND
The control of biofilm adherence on tooth surface has always been the keystone of periodontal therapeutic systems. However, prevalence of gingivitis suggest inadequacy of self-performed oral hygiene measures and need for adjunctive aid for mechanical plaque control. Oral rinses containing chlorhexidine, has been widely used however, with certain limitations. Herbal products have been used widely reflecting its action as alternative and complementary remedy. Hence, the purpose of the present study was to evaluate the antimicrobial and antioxidant efficacy of a Guava leaf extract based mouthrinse in patients with chronic generalized gingivitis as an adjunct to oral prophylaxis.
METHODS METHODS
Sixty subjects (n = 20) in compliance with the inclusion criteria were randomly assigned to one of the 3 study groups i.e. Group A- 0.15%Guava mouth rinse, Group B- 0.2% Chlorhexidine (CHX) mouth rinse, Group C- Distilled water (placebo). All the participants received professional oral prophylaxis and were dispensed with experimental mouth rinses and instructed to use for period of 30 days. Clinical parameters such as gingival index, plaque index along with microbial colony forming units using plaque samples and antioxidant levels in saliva were estimated at baseline, 30 and 90 days' time intervals.
RESULTS RESULTS
All 3 groups showed gradual reduction in GI, PI and microbial counts. Considering the mean scores of recorded parameters at the scheduled time intervals, notable changes were observed between chlorhexidine and guava mouth rinse compared to placebo group. Although there was improvement in the antioxidant status in all study participants, yet there was no statistically significant difference observed.
CONCLUSION CONCLUSIONS
Guava mouth rinse can be used as an empirical adjunct to professional oral prophylaxis owing to its multifactorial properties and favourable acceptance. However, long term studies need to be conducted to validate its use for an extended period of time.
TRIAL REGISTRATION BACKGROUND
The clinical trial has been prospectively registered on 17th February 2017 by the Clinical Trials Registry-India (CTRI/2017/02/007898).

Identifiants

pubmed: 31752836
doi: 10.1186/s12906-019-2745-8
pii: 10.1186/s12906-019-2745-8
pmc: PMC6873761
doi:

Substances chimiques

Anti-Infective Agents, Local 0
Antioxidants 0
Mouthwashes 0
Plant Extracts 0
Chlorhexidine R4KO0DY52L

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

327

Références

J Periodontol. 1965 May-Jun;36:177-87
pubmed: 14296927
J Periodontol. 1970 Jan;41(1):41-3
pubmed: 5264376
Scand J Dent Res. 1971;79(2):119-25
pubmed: 5280246
Phytother Res. 2010 Jun;24(6):817-20
pubmed: 19957242
Acta Odontol Scand. 1963 Dec;21:533-51
pubmed: 14121956
J Med Food. 2014 Jun;17(6):678-85
pubmed: 24738717
J Clin Periodontol. 1998 Jul;25(7):536-41
pubmed: 9696252
Infect Immun. 1982 Nov;38(2):651-67
pubmed: 7141708
Int J Dent Hyg. 2019 Aug;17(3):202-213
pubmed: 30803141
J Periodontol. 1971 Mar;42(3):152-60
pubmed: 4396693
J Periodontol. 1978 May;49(5):245-52
pubmed: 355618
J Clin Pediatr Dent. 2018;42(2):109-113
pubmed: 29087796
Int Dent J. 2004 Oct;54(5):279-83
pubmed: 15503853
J Periodontol. 2016 Nov;87(11):1352-1359
pubmed: 27442086
Planta Med. 2002 Dec;68(12):1149-52
pubmed: 12494352
Periodontol 2000. 1997 Oct;15:52-4
pubmed: 9643232
Food Sci Nutr. 2014 Mar;2(2):174-80
pubmed: 24804076
J Periodontol. 1992 Feb;63(2):118-30
pubmed: 1552465
Biosci Biotechnol Biochem. 2002 Aug;66(8):1727-30
pubmed: 12353635
Anc Sci Life. 1998 Apr;17(4):300-4
pubmed: 22556859
J Clin Periodontol. 2015 Apr;42 Suppl 16:S5-11
pubmed: 25639948
J Zhejiang Univ Sci. 2004 Jun;5(6):676-83
pubmed: 15101101
J Appl Microbiol. 2006 Aug;101(2):487-95
pubmed: 16882158
J Clin Periodontol. 2019 Jul;46(7):723-739
pubmed: 31058336
Ann Intern Med. 2010 Jun 1;152(11):726-32
pubmed: 20335313

Auteurs

Namratha Nayak (N)

Department of Periodontology, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Jothi Varghese (J)

Department of Periodontology, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India. jothimv@gmail.com.

Seema Shetty (S)

Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Vinutha Bhat (V)

Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Tejal Durgekar (T)

Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Richard Lobo (R)

Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Usha Y Nayak (UY)

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Vishwanath U (V)

Department of Biotechnology and Microbiology, Sri Dharmasthala Manjunatheshwara Centre for Research in Ayurveda and Allied Sciences, Kuthpady, Udupi, Karnataka, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH